US 8282926
CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5
granted A61PA61P31/18
Quick answer
US patent 8282926 (CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P31/18